ECP 2019 Final Programme

73 Tuesday, 10 Sept ECP 2019 · Nice Two-Day Symposium for Molecular Biologists e Monday, 9 September 2019 / e Tuesday, 10 September 2019 PS-MD-01 2-Day MD Symposium 09:30–10:30 Agora 3 Poster Session Chair: Sabine Merkelbach-Bruse, Germany 001 Expression of transient receptor potential Vanilloid-1 in gliomas vs medulloblastomas Martha Assimakopoulou, Greece A. Moutafidi, V. Zolota, G. Gatzounis 002 Validation of a novel approach for molecular breast cancer classification Shawn Baldacchino, Malta J. Debattista, C. Saliba, C. Scerri, G. Grech 003 Characterisation of genetic mutation spectra and identification of gene amplification and fusion variants in cell-free nucleic acid from cultured cancer cell media and liquid biopsy specimens using Oncomine™ pan-cancer cell-free assay Ru Cao, USA K. Lea, J. Schageman, K. Hanif, Y. Li, J. Gu, V. Bagai, P. Kshatriya, A. Luchetti, L. Quagliata, H. Wikman, S. Loges, K. Bramlett 004 Case report: NGS of cell-free DNA from blood and bile as a follow-up strategy in a patient with metastatic pancreatic adenocarcinoma Katharina Ebner, Germany C. Driescher, W. Goering, L. Haeberle, V. Keitel, D. Haeussinger, I. Esposito 005 Effect of radio-wave and molecular resonance surgery on rat neck skin regeneration Igor Kastyro, Russia P. Pryanikov, A. Alsufev, V. Popadyuk, A. Kovalenko, A. Sedelnikova, N. Kamanina 006 Up-converting nanoparticles as a tool for histopathological tissue evaluation with multiplexing and machine learning potential Krzysztof Krawczyk, Sweden S. Andersson-Engels, A. Sjögren 007 Pathohistological characteristics of breast cancer in BRCA-positive and BRCA-nega- tive women Snjezana Ramic, Croatia I. Kirac, T. Oresic, T. Zigman, V. Musani, P. Ozretic, O. Vugrek, I. Milas 008 Comparison of four microsatellite instability testing methods in endometrial cancer – reliability, handling, cost effectiveness Janna Siemanowski, Germany B. Schömig-Markiefka, W. Dietmaier, N. Arens, T. Buhl, R. Büttner, S. Merkelbach-Bruse 009 Association between KRAS, NRAS, BRAF mutation status and clinicopathological prognostic factors in colorectal carcinoma in Turkish population Duygu Unal Kocabey, Turkey E. Cakir, F.H. Dilek, B. Bolat Kucukzeybek, A. Calli 010 Results of the Belgian ring trial for liquid biopsy testing in non-small cell lung cancer show variety in the interpretation of the test result Kaat van Casteren, Belgium K. Dufraing, P. Pauwels, N. D’Haene, E. Dequeker 011 Establishment of a 3D histopathology platform for precision tumour diagnosis Jialing Yang, Taiwan Y. Lin, A. Chiang, I. Wang, S. Wu, M. D. Chang, J. Lee, J. Ko, S. Liang, J. Guo, X. Song, H. Huang, M. Chao, C. Lin Monday, 9 Sept